Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Merve İlkay Altuntuğ Cesur, Bilgen Osman, Elif Tümay Özer, Dilayda Kanmaz, Mehmet Baykara & Esra Karaca. (2023) Preparation and characterization of latanoprost-loaded PVA nanofibers as an ocular drug delivery system for glaucoma treatment. International Journal of Polymeric Materials and Polymeric Biomaterials 0:0, pages 1-10.
Read now
Read now
Andrew P Droste & Paula Anne Newman-Casey. (2023) Emerging glaucoma treatments: are we seeing an improvement in adherence?. Expert Review of Ophthalmology 18:2, pages 101-111.
Read now
Read now
Jafar Akbari, Majid Saeedi, Fatemeh Ahmadi, Seyyed Mohammad Hassan Hashemi, Amirhossein Babaei, Sadra Yaddollahi, Seyyed Sohrab Rostamkalaei, Kofi Asare-Addo & Ali Nokhodchi. (2022) Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration. Pharmaceutical Development and Technology 27:5, pages 525-544.
Read now
Read now
Articles from other publishers (10)
Viliana Gugleva & Velichka Andonova. (2023) Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals 16:3, pages 474.
Crossref
Crossref
Ayça Bal-Öztürk, Ece Özcan-Bülbül, Hazal Ezgi Gültekin, Berivan Cecen, Ebru Demir, Atefeh Zarepour, Sibel Cetinel & Ali Zarrabi. (2023) Application of Convergent Science and Technology toward Ocular Disease Treatment. Pharmaceuticals 16:3, pages 445.
Crossref
Crossref
Chirag Patel, Sonal Pande, Vrunda Sagathia, Ketan Ranch, Jayesh Beladiya, Sai H. S. Boddu, Shery Jacob, Moawia M. Al-Tabakha, Nageeb Hassan & Moyad Shahwan. (2023) Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases. Pharmaceutics 15:3, pages 837.
Crossref
Crossref
Yoseph Seo, Hayeon Lim, Hyunjun Park, Jiyun Yu, Jeongyun An, Hah Young Yoo & Taek Lee. (2023) Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications. Pharmaceutics 15:3, pages 772.
Crossref
Crossref
Letizia Pelusi, Domitilla Mandatori, Leonardo Mastropasqua, Luca Agnifili, Marcello Allegretti, Mario Nubile & Assunta Pandolfi. (2023) Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses. Pharmaceutics 15:2, pages 625.
Crossref
Crossref
Phatsawee Jansook & Thorsteinn Loftsson. (2022) Aqueous Prostaglandin Eye Drop Formulations. Pharmaceutics 14:10, pages 2142.
Crossref
Crossref
Lidawani Lambuk, Nurfatihah Azlyna Ahmad Suhaimi, Muhammad Zulfiqah Sadikan, Azliana Jusnida Ahmad Jafri, Suhana Ahmad, Nurul Alimah Abdul Nasir, Vuk Uskoković, Ramlah Kadir & Rohimah Mohamud. (2022) Nanoparticles for the treatment of glaucoma-associated neuroinflammation. Eye and Vision 9:1.
Crossref
Crossref
Lidawani Lambuk, Mohd Aizuddin Mohd Lazaldin, Suhana Ahmad, Igor Iezhitsa, Renu Agarwal, Vuk Uskoković & Rohimah Mohamud. (2022) Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Frontiers in Pharmacology 13.
Crossref
Crossref
Shery Jacob, Anroop B. Nair, Jigar Shah, Sumeet Gupta, Sai H. S. Boddu, Nagaraja Sreeharsha, Alex Joseph, Pottathil Shinu & Mohamed A. Morsy. (2022) Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances. Pharmaceutics 14:3, pages 533.
Crossref
Crossref
Lorena Bonilla, Marta Espina, Patricia Severino, Amanda Cano, Miren Ettcheto, Antoni Camins, Maria Luisa García, Eliana B. Souto & Elena Sánchez-López. (2021) Lipid Nanoparticles for the Posterior Eye Segment. Pharmaceutics 14:1, pages 90.
Crossref
Crossref